NCT05042934 2022-02-10
Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
M.D. Anderson Cancer Center
Columbia University
Washington University School of Medicine
University of Texas Southwestern Medical Center
University of Louisville
Children's Cancer Hospital Egypt 57357